10.1074/jbc.REV120.014294 J
Some individuals notice reduced appetite and weight loss within a few weeks, while for others, it may take several months
Both tirzepatide and B12 injections can provide benefits to individuals who are on their journey to shed excess weight
Regarding the participants with MCI or AD, defined based on a clinical dementia rating (CDR) global score of 0.5 or 1, although the 18-month treatment with exenatide was safe and well-tolerated, it did not significantly affect clinical and cognitive measures, nor did it affect MRI cortical thickness and volume or most biomarkers in the cerebrospinal fluid (CSF), plasma, and plasma neuronal extracellular vesicles (EVs)
While no dose adjustment is required for chronic kidney disease, patients should be monitored for volume depletion due to gastrointestinal adverse effects and potential acute kidney injury risk